Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:40 pm Sale | 2026-03-13 | 13G | GILEAD SCIENCES INC GILD | VANGUARD GROUP INC | 0 0.000% | -111,820,711 (Position Closed) | Filing History |
| 2026-02-23 06:51 am Unchanged | 2026-02-23 | 13D | ARCELLX INC ACLX | GILEAD SCIENCES INC GILD | 6,720,803 11.500% | 0 (Unchanged) | Filing History |
| 2026-02-12 4:39 pm Purchase | 2025-12-31 | 13G | XILIO THERAPEUTICS INC XLO | GILEAD SCIENCES INC GILD | 1,036,977 19.900% | 278,838 (+36.78%) | Filing History |
| 2026-02-12 4:35 pm Sale | 2025-12-31 | 13G | CYPHERPUNK TECHNOLOGIES INC. C CYPH | GILEAD SCIENCES INC GILD | 0 0.000% | -5,319,148 (Position Closed) | Filing History |
| 2026-02-05 1:23 pm Purchase | 2025-12-31 | 13G | GILEAD SCIENCES INC GILD | FMR LLC | 65,539,477 5.300% | 25,860,985 (+65.18%) | Filing History |
| 2025-11-05 5:19 pm Unchanged | 2025-11-03 | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC GILD | 31,424,760 25.600% | 0 (Unchanged) | Filing History |
| 2025-08-14 4:42 pm Purchase | 2025-06-30 | 13G | XILIO THERAPEUTICS INC XLO | GILEAD SCIENCES INC GILD | 758,139 19.900% | 107,750 (+16.57%) | Filing History |
| 2025-08-12 4:30 pm Purchase | 2025-08-08 | 13D | ASSEMBLY BIOSCIENCES INC ASMB | GILEAD SCIENCES INC GILD | 4,505,391 29.000% | 2,295,920 (+103.91%) | Filing History |
| 2025-07-15 7:46 pm Sale | 2025-07-13 | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC GILD | 31,424,760 29.700% | -8,266,889 (-20.83%) | Filing History |
| 2025-05-13 11:44 am Sale | 2025-03-31 | 13G | GILEAD SCIENCES INC GILD | Capital World Investors | 53,834,873 4.300% | -29,863,342 (-35.68%) | Filing History |
| 2025-04-24 09:27 am Sale | 2025-03-31 | 13G | GILEAD SCIENCES INC GILD | BlackRock Inc. BLK | 101,739,273 8.200% | -21,051,024 (-17.14%) | Filing History |
| 2025-03-20 4:32 pm Unchanged | 2025-03-18 | 13G | KALARIS THERAPEUTICS INC KLRS | GILEAD SCIENCES INC GILD | 723,273 3.900% | 0 (Unchanged) | Filing History |
| 2025-03-05 5:00 pm Unchanged | 2025-02-18 | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC GILD | 39,691,649 35.000% | 0 (Unchanged) | Filing History |
| 2025-02-20 7:43 pm Purchase | 2025-02-18 | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC GILD | 39,691,649 35.000% | 8,158,868 (+25.87%) | Filing History |
| 2025-02-13 4:22 pm Sale | 2024-12-31 | 13G | IKENA ONCOLOGY INC IKNA | GILEAD SCIENCES INC GILD | 126,776 3.600% | -117,513 (-48.10%) | Filing History |
| 2025-01-10 3:46 pm Unchanged | 2025-01-07 | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC GILD | 20,981,010 29.900% | 0 (Unchanged) | Filing History |
| 2024-12-23 8:17 pm Purchase | 2024-12-19 | 13D | ASSEMBLY BIOSCIENCES INC ASMB | GILEAD SCIENCES INC GILD | 2,209,471 29.900% | 940,499 (+74.12%) | Filing History |
| 2024-12-19 4:15 pm Purchase | 2024-12-18 | 13G | XILIO THERAPEUTICS INC XLO | GILEAD SCIENCES INC GILD | 650,389 19.900% | 125,712 (+23.96%) | Filing History |
| 2024-06-20 8:35 pm Purchase | 2024-06-17 | 13D | ASSEMBLY BIOSCIENCES INC ASMB | GILEAD SCIENCES INC GILD | 1,268,972 19.990% | 179,500 (+16.48%) | Filing History |
| 2024-05-02 9:29 pm Purchase | 2024-04-30 | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC GILD | 20,981,010 29.900% | 352,081 (+1.71%) | Filing History |